Genome-Based Therapeutics: Targeted Drug Discovery and Development
Publisher: National Academies Press 2012
Number of pages: 89
Objectives: To examine the impact of and investment in genetic and genomic technologies and data in drug discovery and development; To examine and discuss the challenges for incorporating genomic technologies into drug development and to explore solutions to remedy those challenges; To discuss and explore how innovative, novel, and global partnerships between academia, industry, foundations, and government can enable the use of genomic information for more efficient and effective drug discovery and development programs.
Home page url
Download or read it online for free here:
by Niels Bindslev - Co-Action Publishing
This book is a survey of, and evaluates, analytical tools used to determine equilibrium effects of the interactions between ligands and receptive units as obtained from dose-response experimentation and from combinatorial drug therapy.
by Sivakumar Joghi Thatha Gowder (ed.) - InTech
This book covers six sections: Molecular Modeling and Bio-molecular Pharmacology, Immunopharmacology, Environmental Pharmacology and Toxicology, Nanotechnology and Chemotherapy, Drugs and Drug Delivery System and Addiction Pharmacology.
by Paul Heroux - Lulu.com
Contents: Scope of Toxicology; Risk Assessment; Targets and Bio-Transformation; Toxicokinetics; Hemato- and Vascular Toxicity; Dermatotoxicity; Neurotoxicity; Hepatotoxicity; Nephrotoxicity; Techniques In Vivo and In Vitro; Pulmonary Toxicity; etc.
by Wendy L Bennett, et al. - AHRQ
Given the number of medications available for type 2 diabetes mellitus, clinicians and patients need information about their effectiveness to make informed choices. The objective of this review was to summarize the benefits and harms of medications.